AbbVie Inc (BUE:ABBV)
ARS 21100 275 (1.32%) Market Cap: 326.28 Til Enterprise Value: 391.76 Til PE Ratio: 63.33 PB Ratio: 53.42 GF Score: 74/100

Abbvie Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 03, 2021 / 04:40PM GMT
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good afternoon and welcome to the AbbVie portion of Cowen's 41st Annual Health Care Conference. Representing the company is Mike Severino, who's Vice Chairman and President; Rob Michael, who is Executive Vice President and Chief Financial Officer; and Jeff Stewart, who is Executive Vice President of Commercial Operations.

AbbVie has been a favorite of Cowen for several years. And it's quite simple. We don't think the company's growth prospects, new product portfolio and total return opportunity are reflected in the stock. And we feel this is an opportunity for you, investors, who are participating in this session.

Questions & Answers

Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So with that, there's lots of ground to cover in the next 30 minutes. Let's jump right in. Let's start with Humira. Perhaps you can just tell us what level of detailing is Humira receiving today? And is there any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot